TrialBlood2017

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT.

Sung Won Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.